GRB2 and acute myeloid leukemia: This mutation may cause a loss of negative regulation with a decrease in receptor trafficking to lysosome and was previously reported in a pediatric patient with AML [46], In particular, tyrosine 787 is involved in MAPK/ERK1-2 activation pathway by recruitment of GRB2.